Clinical Trial Update: Glucose Disorders Induced by Tacrolimus on Pre Transplantation Endstage Renal Disease Patients [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating glucose disorders associated with tacrolimus in pre-transplant end-stage renal disease patients was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• Prograf (Tacrolimus)
• Tacrolimus (Tacrolimus)

Snippet

Sponsor: Centre Hospitalier Departemental Vendee | Conditions: Kidney Failure, Chronic | Phase 4 | Status: TERMINATED